These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 40120)

  • 21. Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.
    Martorana PA; Kettenbach B; Göbel H; Nitz RE
    Basic Res Cardiol; 1984; 79(5):503-12. PubMed ID: 6439183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of nitrates in the treatment of ischemia].
    Schwinger RH
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S6. PubMed ID: 10818994
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of coronary heart disease].
    Enenkel W
    Wien Med Wochenschr; 1977 Oct; 127(20):624-7. PubMed ID: 21490
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A ten-year reevaluation. Nitroglycerin and isosorbide dinitrate in coronary insufficiency.
    Leslie RE
    Tex Med; 1971 Nov; 67(11):95-8. PubMed ID: 5001168
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of molsidomine on hemodynamics for the patients with chronic heart failure (author's transl)].
    Hayasaki K; Tokunaga M; Kodama H; Kikuchi H; Matsunaga K; Ogata A; Ogawa T
    Kokyu To Junkan; 1981 Mar; 29(3):305-10. PubMed ID: 6894802
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 29. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemodynamic actions of molsidomin in coronary artery disease. Effects on regional myocardial blood flow, segmental ventricular wall motion, ejection phase parameters, ventricular volumes, systemic and pulmonary artery pressures and cardiac output (author's transl)].
    Fleck E; Dirschinger J; Rudolph W
    Herz; 1979 Jun; 4(3):285-92. PubMed ID: 457027
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of beta-adrenergic blockaders and nitrates on left ventricular diastolic function in patients with ischemic heart disease].
    Ivanov I
    Vutr Boles; 1989; 28(1):26-31. PubMed ID: 2568033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug therapy of coronary disease. Nitrates in acute and longtime therapy].
    Lehmann HU; Hochrein H
    Dtsch Med Wochenschr; 1980 Jan; 105(1):7-9. PubMed ID: 6766097
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative ergometric tests in coronary disease patients under betasympathicolysis using Betadrenol and Isoket].
    Raff U; Jeschke D
    Med Welt; 1977 Sep; 28(38):1518-21. PubMed ID: 20547
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceedings: The effect of nitrates on the systemic circulation and the myocardial oxygen consumption].
    Tauchert M; Behrenbeck DW; Niehues B; Hilger HH
    Z Kardiol; 1975; Suppl 2():84. PubMed ID: 812281
    [No Abstract]   [Full Text] [Related]  

  • 35. [Symposium on molsidomin in Moscow. Analysis of a drug against coronary disease].
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1128. PubMed ID: 114780
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sorbonit in coronary disease].
    Chojnowski JR; Adamska-Dyniewska H; Florczak H; Chojnowska-Jezierska J; Mockallo T
    Pol Tyg Lek; 1968 May; 23(21):797-9. PubMed ID: 4875472
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects].
    Metelitsa VI
    Kardiologiia; 1989 Nov; 29(11):57-62. PubMed ID: 2575683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of using corvaton on patients with unstable stenocardia].
    Vakaliuk IP
    Vrach Delo; 1984 Nov; (11):18-21. PubMed ID: 6442043
    [No Abstract]   [Full Text] [Related]  

  • 40. [The normalizing effect of ECG in exercise tolerance tests under molsidomine in different dosages (author's transl].
    Jansen E; Klepzig H
    Med Klin; 1978 Jun; 73(26):983-6. PubMed ID: 672755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.